Animal model for evaluating gastric bleeding and ulcerogenic response induced by aspirin plus clopidogrel

Cell/Tissue Injury and Cytoprotection/Organoprotection in the Gastrointestinal Tract: Mechanisms, Prevention and Treatment

Volumn 30, Issue , 2012, Pages 87-96

  Izuhara, Chitose ^a   Takayama, Shinichi ^a   Itayama, Misaki ^a   Hoshin, Naoto ^a   Yoshida, Yuji ^a   Takeuchi, Koji ^a  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84875776945     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1159/000338466     Document Type: Chapter

References (24)

1. Antiplatelet Trialists' Collaboration: Collaborative overview of randomised trials of antiplatelet therapy-I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994;308:81-106.
2. Wolfe MM, Lichtenstein DR, Singh G: Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. N Engl J Med 1999;340:1888-1899.
3. Hallas J, Dall M, Andries A, et al: Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding: population based case-control study. BMJ 2006;333:726.
4. Uchiyama S, Yamazaki M, Nakamura T, et al: New modalities and aspects of antiplatelet therapy for stroke prevention. Cerebrovasc Dis 2006;21(suppl I): 7-16.
5. CAPRIE Steering Committee: A randomized, blinded trial of clopidogrel versus aspirin in patients at risk of ischemic events (CAPRIE). Lancet 1996;348:1329-1339.
6. Ghassemi KA, Kovacs TO, Jensen DM: Gastric acid inhibition in the treatment of peptic ulcer hemorrhage. Curr Gastroenterol Rep 2009;11:462-469.
7. van Rensburg C, Barkun AN, Racz I, Fedorak R, Bornman PC, Beglinger C, Balanzó J, Devière J, Kupcinskas L, Luehmann R, Doerfler H, Schäfer-Preuss S: Clinical trial: intravenous pantoprazole vs. ranitidine for the prevention of peptic ulcer rebleeding. A multicentre, multinational, randomized trial. Aliment Pharmacol Ther 2009;229:497-507.
8. Gill JM, Player MS, Metz DC: Balancing the risks and benefits of proton pump inhibitors. Ann Fam Med 2011;9:200-202.
9. Dorsam RT, Kunapuli SP: Central role of the P2Y12 receptor in platelet activation. J Clin Invest 2004;113:340-345.
10. Yamasaki K, Izuhara C, Honda M, Nishio H, Takeuchi K: Aggravation by clopidogrel, an antiplatelet drug, of antral ulcers induced by NSAID in rats. A prophylactic effect of famotidine. Pharma Med 2009;27:106-115.
11. Izuhara C, Yamasaki K, Honda M, Nishio H, Takeuchi K: Aggravation by clopidogrel, an antiplatelet drug, of HCl/aspirin-induced gastric bleeding and lesions in rats: prophylactic effect of rebamipide. Jpn Pharmacol Ther 2010;38:333-345.
12. Izuhara C, Takayama S, Yamada N, Kimura M, Takeuchi K: Aggravation by clopidogrel, an antiplatelet drug, of HCl/aspirin-induced gastric hemorrhagic lesions in rats: prophylactic effect of irsogladine. Jpn Pharmacol Ther 2011;39:421-435.
13. Holzer P, Pabst MA, Lippe ITh: Intragastric capsaicin protects against aspirin-induced lesion formation and bleeding in the rat gastric mucosa. Gastroenterology 1986;96:1425-1433.
14. Ghassemi KA, Kovacs TO, Jensen DM: Gastric acid inhibition in the treatment of peptic ulcer hemorrhage. Curr Gastroenterol Rep 2009;11:462-469.
15. Okabe S, Takeuchi K, Nakamura K, Takagi K: Pathogenesis of gastric lesions induced by aspirin in the pylorus-ligated rats. Jpn J Pharmacol 1974;24:363-371.
16. Ritchie WP: Acute gastric mucosal damage induced by bile salts, acid, and ischemia. Gastroenterology 1975;68:699-707.
17. Davenport HW: Gastric mucosal hemorrhage in dogs. Effects of acid, aspirin, and alcohol. Gastroenterology 1969;56:439-449.
18. Takeuchi K, Ueki S, Tanaka H: Endogenous prostaglandins in gastric alkaline response in the rat stomach after damage. Am J Physiol 1986;250:G842-G849.
19. Mashita Y, Taniguchi M, Yokota A, Tanaka A, Takeuchi K: Oral but not parenteral aspirin upregulates COX-2 expression in rat stomachs. A relationship between COX-2 expression and PG deficiency. Digestion 2006;73:124-132.
20. Izuhara C, Takayama S, Yamada N, et al: A new model of gastric bleeding induced in rats by aspirin plus clopidogrel under stimulation of acid secretion:prophylactic effects of antiulcer drugs. J Physiol Pharmacol 2012; in press.
21. Ogino K, Hobara T, Ishiyama H, Yamasaki K, Kobayashi H, Izumi Y, Oka S: Antiulcer mechanism of action of rebamipide, a novel antiulcer compound, on diethyldithiocarbamate-induced antral gastric ulcers in rats. Eur J Pharmacol 1992;212:9-13.
22. Sakurai K, Osaka T, Yamasaki K: Rebamipide reduces recurrence of experimental gastric ulcers:role of free radicals and neutrophils. Dig Dis Sci 2005;50:S90-S96.
23. Terano A, Hiraishi H, Ota S, Sugimoto T: Geranylgeranylacetone, a novel anti-ulcer drug, stimulates mucus synthesis and secretion in rat gastric cultured cells. Digestion 1986;33:206-210.
24. Suemasu S, Tanaka K, Namba T, Ishihara T, Katsu T, Fujimoto M, Adachi H, Sobue G, Takeuchi K, Nakai A, Mizushima T: A role for HSP70 in protecting against indomethacin-induced gastric lesions. J Biol Chem 2009;284:19705-19715.